Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials-Reference-Cited by-同舟云学术

Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials

Published:2001-07 Issue:2 Volume:63 Page:187-195
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Pérez de los Cobos José,Duro Pilar,Trujols Joan,Tejero Antoni,Batlle Fanny,Ribalta Elisa,Casas Miquel

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference30 articles.

1. Amantadine may facilitate detoxification of cocaine addicts;Alterman;Drug Alcohol Depend.,1992

2. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence;Alterman;Drug Alcohol Depend.,1997

3. An inventory for measuring depression;Beck;Arch. Gen. Psychiatry,1961

4. Inhibition of the morphine withdrawal syndrome by a novel muscarinic antagonist (4-DAMP);Buccafusco;Life Sci.,1990

5. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies;Danysz;Neurosci. Biobehav. Rev.,1997

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders due to Substance Use: Stimulants;Tasman’s Psychiatry;2024

2. Disorders Due to Substance Use: Stimulants;Tasman’s Psychiatry;2023

3. Effect of add-on amantadine to clonidine on opioid withdrawal symptoms in opioid-dependent patients detoxified with buprenorphine: a randomized controlled trial;Journal of Substance Use;2022-08-15

4. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review;Drug and Alcohol Dependence;2020-03

5. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence;Journal of Pharmacology and Experimental Therapeutics;2019-08-07